You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Translocation carcinoma

Showing 1 - 25 of 7,897
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MiT Family Translocation Renal Cell Carcinomas (IMCOR)

Not yet recruiting
  • Renal Carcinoma
  • Data collection
  • Bordeaux, France
  • +3 more
Jul 8, 2022

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life

Active, not recruiting
  • FGFR1 Gene Amplification
  • +18 more
  • Scottsdale, Arizona
  • +5 more
Oct 18, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Active, not recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +18 more
Feb 14, 2022

Anaplastic Lymphoma Kinase Gene Translocation, NSCLC Trial in Boston

Recruiting
  • Anaplastic Lymphoma Kinase Gene Translocation
  • Non-Small Cell Lung Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 14, 2022

    NSCLC Trial in Seoul (Atezolizumab(Tecentriq), Pemetrexed, Bevacizumab)

    Recruiting
    • Non-small Cell Lung Cancer
    • Seoul, Gangnamgu, Korea, Republic of
      Samsung Medical Center
    Dec 27, 2021

    Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

    Recruiting
    • Renal Cell Carcinoma
    • +5 more
    • Albury, New South Wales, Australia
    • +10 more
    Feb 14, 2022

    ALK or ROS1-positive NSCLC Trial in China (Crizotinib)

    Active, not recruiting
    • ALK or ROS1-positive NSCLC
    • Fuzhou, Fujian, China
    • +9 more
    Aug 30, 2022

    Acquired Clinical Resistance to Crizotinib in Non-small Cell

    Completed
    • Lung Cancer
    • obtain tissue specimens
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 6, 2021

    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • Birmingham, Alabama
    • +255 more
    Aug 24, 2022

    Cirrhosis, Hepatic Encephalopathy, Ascites Trial (Allopurinol 300 MG, Simvastatin 40mg, Placebo)

    Not yet recruiting
    • Cirrhosis
    • +4 more
    • Allopurinol 300 MG
    • +2 more
    • (no location specified)
    Aug 22, 2022

    Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

    Not yet recruiting
    • Locally Advanced Urothelial Carcinoma
    • +3 more
    • (no location specified)
    Sep 15, 2022

    Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)

    Completed
    Has Results
    • Non Small Cell Lung Cancer
    • +2 more
    • Hefei, Anhui, China
    • +43 more
    Feb 3, 2021

    Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)

    Completed
    • Recurrent ACC, metastaticACC, Unreaectable ACC
    • Seoul, Korea, Republic of
      Department of Internal Medicine, Seoul National University Hospi
    Mar 26, 2022

    NSCLC Trial in Italy (Lorlatinib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Meldola, Forlì- Cesena, Italy
    • +19 more
    Jul 13, 2021

    Soluble Mediators, Cytokines, and Circulating Angiogenic Factors

    Active, not recruiting
    • Non-small Cell Lung Cancer
      • Elche, Alicante, Spain
      • +24 more
      Nov 8, 2022

      Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

      Recruiting
      • Papillary Thyroid Cancer
        • Milan, Italy
          Istituto Auxologico Italiano
        Mar 2, 2023

        NSCLC (NSCLC) Trial in Worldwide (Crizotinib, Pemetrexed/Cisplatin, Pemetrexed/Carboplatin)

        Completed
        Has Results
        • NSCLC (Non-small Cell Lung Cancer)
        • Hefei, Anhui, China
        • +46 more
        Nov 16, 2020

        To Evaluate the Clinical Efficacy and Safety of the New ALSS Trial in Wuhan (New artificial liver CABA system (BS330+CA280) +PE)

        Recruiting
        • To Evaluate the Clinical Efficacy and Safety of the New ALSS
        • New artificial liver CABA system (BS330+CA280) +PE
        • Wuhan, Hubei, China
          Tongji Hospital
        Mar 21, 2023

        NSCLC Trial in Hangzhou (pablizumab combined with apatinib and neoadjuvant chemo)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • pablizumab combined with apatinib and neoadjuvant chemotherapy
        • Hangzhou, Zhejiang, China
          2nd Affiliated Hospital, School of Medicine, Zhejiang University
        Jul 18, 2021

        French National Observatory of Non-small Cell Lung and Molecular

        Completed
        • Carcinoma, Non-Small-Cell Lung
        • +3 more
          • Agen, France
          • +132 more
          Jun 29, 2022

          Macular Holes Trial in Shanghai (Translocation ILM Flap, ILM Peeling)

          Recruiting
          • Macular Holes
          • Translocation ILM Flap
          • ILM Peeling
          • Shanghai, China
            Xinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
          Sep 25, 2023

          Decompensated Cirrhosis Trial (Isomaltooligosaccharides (IMO))

          Not yet recruiting
          • Decompensated Cirrhosis
          • Isomaltooligosaccharides (IMO)
          • (no location specified)
          Nov 12, 2023

          Schistosoma Related Bladder Diseases.

          Not yet recruiting
          • Schistosoma Haematobium
          • Immunohistochemistry staining,
          • microscopic examination of urine
          • Assiut, Egypt
            Assiut University Hospital
          Jul 4, 2023

          Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in

          Recruiting
          • Advanced Lung Non-Small Cell Carcinoma
          • +9 more
          • Biopsy
          • +2 more
          • Duarte, California
            City of Hope Medical Center
          Aug 2, 2022

          Secondary Sclerosis Cholangitis Prospective

          Recruiting
          • Secondary Sclerosis Cholangitis in Critically Ill Patients
            • Graz, Austria
              Medical University Graz
            Sep 26, 2022